A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)
Clinical trial NCT03595657 · COMPLETED
Trial details
- NCT number
- NCT03595657
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2023-03-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.